创建当前的良好制造实践-使用自动化生物反应器等级的介质细胞流体细胞衍生的细胞外囊
Elani F Wiest1, Abba C Zubair1,2
1Department of Regenerative Biotherapeutics, Mayo Clinic, Jacksonville, FL 32224, USA.
Biology
|March 26, 2025
概括
使用介质细胞 (MSCs) 进行细胞外囊泡 (EVs) 的自动化生物制造提供了一个可扩展的解决方案. 这种方法解决了用于治疗应用的cGMP级电动汽车生产的标准化和一致性挑战.
科学领域:
- 生物技术是生物技术.
- 细胞生物学 细胞生物学
- 制造业科学 制造业科学
背景情况:
- 越来越多的人对当前良好的制造实践 (cGMP) 级外细胞囊泡 (EV) 产生兴趣,用于治疗.
- 电动汽车生产的挑战包括缺乏标准化和可扩展性.
- 介酶体 stromal 细胞 (MSCs) 是产生治疗性 EVs 的关键来源.
研究的目的:
- 审查从MSC调节介质中自动化生物制造电动汽车.
- 讨论影响自动化系统中电动汽车数量和质量的因素.
- 为突出cGMP-EV生产的验证和监管方面的考虑.
主要方法:
- 对EV生产的自动化细胞培养系统的审查.
- 从自动化系统中分析电动汽车隔离技术.
- 对cGMP-EVs的验证策略的讨论.
主要成果:
- 自动化生物制造系统可以提高电动汽车生产的可扩展性和可重复性.
- 确定了影响自动化系统电动汽车产量和纯度的关键因素.
- 概述了确保cGMP级电动汽车质量的验证步骤,包括FDA标准.
结论:
- 自动化生物制造,特别是使用封闭系统生物反应器,对于可扩展,经济和可重复的cGMP-EV生产至关重要.
- 解决标准化和详细表征对于监管合规和治疗应用至关重要.
- 确保批量一致性和满足FDA对身份,安全,纯度和功效的标准对于cGMP-EVs至关重要.
相关概念视频
Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Bioreactor Controls-II
In aerobic fermentations, oxygen is vital for microbial growth and metabolite production. Since air comprises only about 20% oxygen and the gas is poorly soluble in water—just 9 ppm at 20°C—supplying sufficient oxygen becomes a critical challenge, especially in high-demand processes like yeast growth or citric acid production. Even a fully saturated broth may offer only a few seconds of oxygen availability.To address this, sterile or scrubbed air is introduced into the fermentor via a sparger...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...


